GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (B3PN94)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (B3PN94) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B3PN94
Type
protein
Length
419 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9F605311B7e26e76340423EfAfbE5e2EFc7A0b7C
Molecule
Serine hydroxymethyltransferase
UniProt
B3PN94
Pockets
4 · best druggability 0.58

Structure

1 distinct chain · 46% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein41946% helix, 14% strandB3PN94

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13300.580.7747empty
21770.440.7426empty
3530.340.7814empty
4610.320.7617empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.